Despite more than 600 reports of "adverse events" for medicinal cannabis in the past three years, the Therapeutic Goods Administration (TGA) is yet to investigate the safety of most medicinal cannabis products. It has now launched a review.

The whole article is worth reading but this caught my eye.

The Australian Medicinal Cannabis Association (AMCA) said that without suspected adverse events being published and investigated it was hard to draw conclusions about the safety of medicinal cannabis products.

If the only organisation representing cannabis prescribers is unwilling to comment on safety what does that say about the state of the industry?

  • Joshi@slrpnk.netOPEnglish
    0·
    29 days ago

    No, I believe I approach the literature with an open mind and while I don’t prescribe cannabis myself I do frequently refer patients who i think will benefit. The fact that there is legitimate use of cannabis in medical settings does not mean that it isn’t being over-prescribed and under regulated.

    Incidentally the reason i don’t prescribe myself is purely as I don’t have capacity to add another string to my bow in my already busy practice.